| Line item | 2026-01-31 FY | 2025-07-31 FY | 2024-07-31 FY | 2023-07-31 FY | 2022-07-31 FY | 2021-07-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $377.56K | $3.56M | -$2.54M | -$927.92K | -$1.13M | -$254.17K |
| R&D | – | – | – | – | – | – |
| SG&A | – | $57.93K | $52.70K | $46.36K | $42.04K | $38.38K |
| Operating Income | – | – | -$2.44M | -$910.43K | -$997.85K | -$116.42K |
| Interest Expense | $0.00 | $10.00 | $2.14K | $1.11K | $0.00 | $0.00 |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $36.45K |
| Net Income | -$340.67K | -$3.47M | -$2.44M | -$910.43K | -$997.85K | -$116.42K |
| EPS (basic) | 0.0000 | -0.0600 | 0.0500 | -0.0200 | -0.0300 | 0.0000 |
| EPS (diluted) | 0.0000 | -0.0600 | 0.0500 | -0.0200 | -0.0300 | 0.0000 |
| Shares (diluted) | – | – | – | $43.22M | $37.16M | $39.18M |